United States Restriction Endonucleases Market by Manufacturers, States, Type and Application, Forecast to 2022

June 2017 | 120 pages | ID: UB985A29BC3EN
GlobalInfoResearch

Abstracts

Restriction Endonuclease is an enzyme that cuts DNA at or near specific recognition nucleotide sequences known as restriction sites. They are the enzymes that are found in the bacteria and are harvested from them for their use in research and commercial aspects. Restriction enzymes are commonly classified into four types, which differ in their structure and whether they cut their DNA substrate at their recognition site, or if the recognition and cleavage sites are separate from one another.

Scope of the Report:

This report focuses on the Restriction Endonucleases in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers

• New England Biolabs
• Thermo Fisher Scientific
• Takara Bio
• Illumina
• Agilent Technologies
• Roche
• GE Healthcare
• Promega Corporation
• Qiagen
• Jena Biosciences

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Market Segment by Type, covers

• Type I
• Type II
• Type III
• Type IV
• Others

Market Segment by Applications, can be divided into

• Academic & Research Institutes
• Hospitals & Diagnostic Centers
• Biopharmaceutical
• Other

There are 17 Chapters to deeply display the United States Restriction Endonucleases market.

Chapter 1, to describe Restriction Endonucleases Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Restriction Endonucleases, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Restriction Endonucleases, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Restriction Endonucleases market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Restriction Endonucleases Research Findings and Conclusion, Appendix, methodology and data source.

Contents

1 MARKET OVERVIEW

1.1 Restriction Endonucleases Introduction
1.2 Market Analysis by Type
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
  1.2.4 Type IV
  1.2.5 Others
1.3 Market Analysis by Applications
  1.3.1 Academic & Research Institutes
  1.3.2 Hospitals & Diagnostic Centers
  1.3.3 Biopharmaceutical
  1.3.4 Other
1.4 Market Analysis by States
  1.4.1 California Status and Prospect (2012-2022)
  1.4.2 Texas Status and Prospect (2012-2022)
  1.4.3 New York Status and Prospect (2012-2022)
  1.4.4 Florida Status and Prospect (2012-2022)
  1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 New England Biolabs
  2.1.1 Profile
  2.1.2 Restriction Endonucleases Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 New England Biolabs Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 New England Biolabs News
2.2 Thermo Fisher Scientific
  2.2.1 Profile
  2.2.2 Restriction Endonucleases Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Thermo Fisher Scientific Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Thermo Fisher Scientific News
2.3 Takara Bio
  2.3.1 Profile
  2.3.2 Restriction Endonucleases Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Takara Bio Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Takara Bio News
2.4 Illumina
  2.4.1 Profile
  2.4.2 Restriction Endonucleases Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Illumina Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Illumina News
2.5 Agilent Technologies
  2.5.1 Profile
  2.5.2 Restriction Endonucleases Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Agilent Technologies Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 Agilent Technologies News
2.6 Roche
  2.6.1 Profile
  2.6.2 Restriction Endonucleases Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Roche Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Roche News
2.7 GE Healthcare
  2.7.1 Profile
  2.7.2 Restriction Endonucleases Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 GE Healthcare Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 GE Healthcare News
2.8 Promega Corporation
  2.8.1 Profile
  2.8.2 Restriction Endonucleases Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Promega Corporation Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.8.4 Business Overview
  2.8.5 Promega Corporation News
2.9 Qiagen
  2.9.1 Profile
  2.9.2 Restriction Endonucleases Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Qiagen Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.9.4 Business Overview
  2.9.5 Qiagen News
2.10 Jena Biosciences
  2.10.1 Profile
  2.10.2 Restriction Endonucleases Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 Jena Biosciences Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.10.4 Business Overview
  2.10.5 Jena Biosciences News

3 UNITED STATES RESTRICTION ENDONUCLEASES MARKET COMPETITION, BY MANUFACTURER

3.1 United States Restriction Endonucleases Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Restriction Endonucleases Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Restriction Endonucleases Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Restriction Endonucleases Manufacturer Market Share
  3.4.2 Top 5 Restriction Endonucleases Manufacturer Market Share
3.5 Market Competition Trend

4 UNITED STATES RESTRICTION ENDONUCLEASES MARKET ANALYSIS BY STATES

4.1 United States Restriction Endonucleases Sales Market Share by States
4.2 United States Restriction Endonucleases Sales by States (2012-2017)
4.3 United States Restriction Endonucleases Revenue (Value) by States (2012-2017)

5 UNITED STATES MARKET SEGMENTATION RESTRICTION ENDONUCLEASES BY TYPE

5.1 United States Restriction Endonucleases Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 United States Restriction Endonucleases Sales and Market Share by Type (2012-2017)
  5.1.2 United States Restriction Endonucleases Revenue and Market Share by Type (2012-2017)
5.2 Type I Sales Growth and Price
  5.2.1 United States Type I Sales Growth (2012-2017)
  5.2.2 United States Type I Price (2012-2017)
5.3 Type II Sales Growth and Price
  5.3.1 United States Type II Sales Growth (2012-2017)
  5.3.2 United States Type II Price (2012-2017)
5.4 Type III Sales Growth and Price
  5.4.1 United States Type III Sales Growth (2012-2017)
  5.4.2 United States Type III Price (2012-2017)
5.5 Type IV Sales Growth and Price
  5.5.1 United States Type IV Sales Growth (2012-2017)
  5.5.2 United States Type IV Price (2012-2017)
5.6 Others Sales Growth and Price
  5.6.1 United States Others Sales Growth (2012-2017)
  5.6.2 United States Others Price (2012-2017)

6 UNITED STATES MARKET SEGMENTATION RESTRICTION ENDONUCLEASES BY APPLICATION

6.1 United States Restriction Endonucleases Sales Market Share by Application (2012-2017)
6.2 Academic & Research Institutes Sales Growth (2012-2017)
6.3 Hospitals & Diagnostic Centers Sales Growth (2012-2017)
6.4 Biopharmaceutical Sales Growth (2012-2017)
6.5 Other Sales Growth (2012-2017)

7 CALIFORNIA RESTRICTION ENDONUCLEASES SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 California Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017)
7.2 California Restriction Endonucleases Sales and Market Share by Type
7.3 California Restriction Endonucleases Sales by Application (2012-2017)

8 NEW YORK RESTRICTION ENDONUCLEASES SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 New York Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Restriction Endonucleases Sales and Market Share by Type
8.3 New York Restriction Endonucleases Sales by Application (2012-2017)

9 TEXAS RESTRICTION ENDONUCLEASES SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Texas Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Restriction Endonucleases Sales and Market Share by Type
9.3 Texas Restriction Endonucleases Sales by Application (2012-2017)

10 FLORIDA RESTRICTION ENDONUCLEASES SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

10.1 Florida Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Restriction Endonucleases Sales and Market Share by Type
10.3 Florida Restriction Endonucleases Sales by Application (2012-2017)

11 ILLINOIS RESTRICTION ENDONUCLEASES SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

11.1 Illinois Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Restriction Endonucleases Sales and Market Share by Type
11.3 Illinois Restriction Endonucleases Sales by Application (2012-2017)

12 RESTRICTION ENDONUCLEASES MARKET FORECAST (2017-2022)

12.1 United States Restriction Endonucleases Sales, Revenue and Growth Rate (2017-2022)
12.2 Restriction Endonucleases Market Forecast by States (2017-2022)
12.3 Restriction Endonucleases Market Forecast by Type (2017-2022)
12.4 Restriction Endonucleases Market Forecast by Application (2017-2022)

13 RESTRICTION ENDONUCLEASES MANUFACTURING COST ANALYSIS

13.1 Restriction Endonucleases Key Raw Materials Analysis
  13.1.1 Key Raw Materials
  13.1.2 Price Trend of Key Raw Materials
  13.1.3 Key Suppliers of Raw Materials
  13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
  13.2.1 Raw Materials
  13.2.2 Labor Cost
  13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Restriction Endonucleases

14 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

14.1 Restriction Endonucleases Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Restriction Endonucleases Major Manufacturers in 2016
14.4 Downstream Buyers

15 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

15.1 Sales Channel
  15.1.1 Direct Marketing
  15.1.2 Indirect Marketing
  15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Restriction Endonucleases Picture
Table Product Specifications of Restriction Endonucleases
Figure United States Sales Market Share of Restriction Endonucleases by Types in 2016
Table Types of Restriction Endonucleases
Figure Type I Picture
Table Major Manufacturers of Type I
Figure Type II Picture
Table Major Manufacturers of Type II
Figure Type III Picture
Table Major Manufacturers of Type III
Figure Type IV Picture
Table Major Manufacturers of Type IV
Figure Others Picture
Table Major Manufacturers of Others
Table United States Restriction Endonucleases Sales Market Share by Applications in 2016
Table Applications of Restriction Endonucleases
Figure Academic & Research Institutes Picture
Figure Hospitals & Diagnostic Centers Picture
Figure Biopharmaceutical Picture
Figure Other Picture
Figure California Restriction Endonucleases Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Restriction Endonucleases Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Restriction Endonucleases Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Restriction Endonucleases Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Restriction Endonucleases Revenue (Million USD) and Growth Rate (2012-2022)
Table New England Biolabs Basic Information, Manufacturing Base and Competitors
Table New England Biolabs Restriction Endonucleases Type and Applications
Table New England Biolabs Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific Restriction Endonucleases Type and Applications
Table Thermo Fisher Scientific Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takara Bio Basic Information, Manufacturing Base and Competitors
Table Takara Bio Restriction Endonucleases Type and Applications
Table Takara Bio Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Illumina Basic Information, Manufacturing Base and Competitors
Table Illumina Restriction Endonucleases Type and Applications
Table Illumina Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table Agilent Technologies Restriction Endonucleases Type and Applications
Table Agilent Technologies Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Restriction Endonucleases Type and Applications
Table Roche Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GE Healthcare Basic Information, Manufacturing Base and Competitors
Table GE Healthcare Restriction Endonucleases Type and Applications
Table GE Healthcare Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Promega Corporation Basic Information, Manufacturing Base and Competitors
Table Promega Corporation Restriction Endonucleases Type and Applications
Table Promega Corporation Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Qiagen Basic Information, Manufacturing Base and Competitors
Table Qiagen Restriction Endonucleases Type and Applications
Table Qiagen Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jena Biosciences Basic Information, Manufacturing Base and Competitors
Table Jena Biosciences Restriction Endonucleases Type and Applications
Table Jena Biosciences Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Restriction Endonucleases Sales by Manufacturer (2016-2017)
Figure United States Restriction Endonucleases Sales Market Share by Manufacturer in 2016
Figure United States Restriction Endonucleases Sales Market Share by Manufacturer in 2017
Table United States Restriction Endonucleases Revenue by Manufacturer (2016-2017)
Figure United States Restriction Endonucleases Revenue Market Share by Manufacturer in 2015
Figure United States Restriction Endonucleases Revenue Market Share by Manufacturer in 2016
Table United States Restriction Endonucleases Price by Manufacturers (2016-2017)
Figure Top 3 Restriction Endonucleases Manufacturer Market Share in 2016
Figure Top 3 Restriction Endonucleases Manufacturer Market Share in 2017
Figure Top 5 Restriction Endonucleases Manufacturer Market Share in 2016
Figure Top 5 Restriction Endonucleases Manufacturer Market Share in 2017
Figure United States Restriction Endonucleases Sales and Growth (2012-2017)
Table United States Restriction Endonucleases Sales by States (2012-2017)
Table United States Restriction Endonucleases Sales Market Share by States (2012-2017)
Figure United States 2012 Restriction Endonucleases Sales Market Share by States
Figure United States 2016 Restriction Endonucleases Sales Market Share by States
Figure United States Restriction Endonucleases Revenue and Growth (2012-2017)
Table United States Restriction Endonucleases Revenue by States (2012-2017)
Table United States Restriction Endonucleases Revenue Market Share by States (2012-2017)
Table United States 2012 Restriction Endonucleases Revenue Market Share by States
Table United States 2016 Restriction Endonucleases Revenue Market Share by States
Table United States Restriction Endonucleases Sales by Type (2012-2017)
Table United States Restriction Endonucleases Sales Share by Type (2012-2017)
Table United States Restriction Endonucleases Revenue by Type (2012-2017)
Table United States Restriction Endonucleases Revenue Share by Type (2012-2017)
Figure United States Type I Sales Growth (2012-2017)
Figure United States Type I Price (2012-2017)
Figure United States Type II Sales Growth (2012-2017)
Figure United States Type II Price (2012-2017)
Figure United States Type III Sales Growth (2012-2017)
Figure United States Type III Price (2012-2017)
Figure United States Type IV Sales Growth (2012-2017)
Figure United States Type IV Price (2012-2017)
Figure United States Others Sales Growth (2012-2017)
Figure United States Others Price (2012-2017)
Table United States Restriction Endonucleases Sales by Application (2012-2017)
Table United States Restriction Endonucleases Sales Share by Application (2012-2017)
Figure United States Academic & Research Institutes Sales Growth (2012-2017)
Figure United States Hospitals & Diagnostic Centers Sales Growth (2012-2017)
Figure United States Biopharmaceutical Sales Growth (2012-2017)
Figure United States Other Sales Growth (2012-2017)
Figure California Restriction Endonucleases Revenue and Growth (2012-2017)
Figure California Restriction Endonucleases Sales and Growth (2012-2017)
Table California Restriction Endonucleases Sales by Type (2012-2017)
Table California Restriction Endonucleases Sales Market Share by Type (2012-2017)
Table California Restriction Endonucleases Sales by Application (2012-2017)
Table California Restriction Endonucleases Sales Market Share by Application (2012-2017)
Figure New York Restriction Endonucleases Revenue and Growth (2012-2017)
Figure New York Restriction Endonucleases Sales and Growth (2012-2017)
Table New York Restriction Endonucleases Sales by Type (2012-2017)
Table New York Restriction Endonucleases Sales Market Share by Type (2012-2017)
Table New York Restriction Endonucleases Sales by Application (2012-2017)
Table New York Restriction Endonucleases Sales Market Share by Application (2012-2017)
Figure Texas Restriction Endonucleases Revenue and Growth (2012-2017)
Figure Texas Restriction Endonucleases Sales and Growth (2012-2017)
Table Texas Restriction Endonucleases Sales by Type (2012-2017)
Table Texas Restriction Endonucleases Sales Market Share by Type (2012-2017)
Table Texas Restriction Endonucleases Sales by Application (2012-2017)
Table Texas Restriction Endonucleases Sales Market Share by Application (2012-2017)
Figure Florida Restriction Endonucleases Revenue and Growth (2012-2017)
Figure Florida Restriction Endonucleases Sales and Growth (2012-2017)
Table Florida Restriction Endonucleases Sales by Type (2012-2017)
Table Florida Restriction Endonucleases Sales Market Share by Type (2012-2017)
Table Florida Restriction Endonucleases Sales by Application (2012-2017)
Table Florida Restriction Endonucleases Sales Market Share by Application (2012-2017)
Figure Illinois Restriction Endonucleases Revenue and Growth (2012-2017)
Figure Illinois Restriction Endonucleases Sales and Growth (2012-2017)
Table Illinois Restriction Endonucleases Sales by Type (2012-2017)
Table Illinois Restriction Endonucleases Sales Market Share by Type (2012-2017)
Table Illinois Restriction Endonucleases Sales by Application (2012-2017)
Table Illinois Restriction Endonucleases Sales Market Share by Application (2012-2017)
Figure United States Restriction Endonucleases Sales, Revenue and Growth Rate (2017-2022)
Table United States Restriction Endonucleases Sales Forecast by States (2017-2022)
Table United States Restriction Endonucleases Market Share Forecast by States (2017-2022)
Table United States Restriction Endonucleases Sales Forecast by Type (2017-2022)
Table United States Restriction Endonucleases Market Share Forecast by Type (2017-2022)
Table United States Restriction Endonucleases Sales Forecast by Application (2017-2022)
Table United States Restriction Endonucleases Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Restriction Endonucleases
Figure Manufacturing Process Analysis of Restriction Endonucleases
Figure Restriction Endonucleases Industrial Chain Analysis
Table Raw Materials Sources of Restriction Endonucleases Major Manufacturers in 2016
Table Major Buyers of Restriction Endonucleases
Table Distributors/Traders/ Dealers List